BDNF and irritable bowel syndrome: Clinical and preclinical studies suggested that BDNF acts on the intestinal sensory nerve endings, may promote their growth and synapse formation and alter epithelial barrier, which lead to visceral hypersensitivity in IBS patient and CACS-induced mouse model (Yu et al., 2012, 2015, 2017).